Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis

Diseases of the Esophagus

Volumn 25, Issue 7, 2012, Pages 614-622

  Hayashi, Y ^a   Correa, A M ^a   Hofstetter, W L ^a   Vaporciyan, A A ^a   Mehran, R J ^a   Rice, D C ^a   Suzuki, A ^a   Lee, J H ^a   Bhutani, M S ^a   Welsh, J ^a   Lin, S H ^a   Maru, D M ^a   Swisher, S G ^a   Ajani, J A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diabetes; Esophageal cancer; High body mass index; Surgical complication; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; AGE; ALCOHOL ABUSE; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROESOPHAGEAL REFLUX; HIGH BODY MASS INDEX; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; WEIGHT REDUCTION;

ADENOCARCINOMA; AGE FACTORS; AGED; BODY MASS INDEX; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84866297041     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01290.x     Document Type: Article

References (25)

1. Finucane M M, Stevens G A, Cowan M J etal. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557-67.
2. Ogden C L, Carroll M D, Curtin L R, McDowell M A, Tabak C J, Flegal K M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
3. Calle E E, Rodriguez C, Walker-Thurmond K, Thun M J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38.
4. Brown L M, Devesa S S, Chow W H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-7.
5. Brown L M, Swanson C A, Gridley G etal. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995; 87: 104-9.
6. Hampel H, Abraham N S, El-Serag H B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211.
7. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-90.
8. Hayashi Y, Correa A M, Hofstetter W L etal. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 2010; 116: 5619-27.
9. Morgan M A, Lewis W G, Hopper A N etal. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus 2007; 20: 29-35.
10. Healy L A, Ryan A M, Gopinath B, Rowley S, Byrne P J, Reynolds J V. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg 2007; 134: 1284-91.
11. Kilic A, Schuchert M J, Pennathur A etal. Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg 2009; 87: 412-15.
12. Greene F L, Page D L, Fleming I D etal. AJCC Cancer Staging Handbook, 6th edn. New York: Springer-Verlag, 2002.
13. Blackstone E H. Comparing apples and oranges. J Thorac Cardiovasc Surg 2002; 123: 8-15.
14. Corley D A, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008; 17: 352-8.
15. Balbuena L, Casson A G. Physical activity, obesity and risk for esophageal adenocarcinoma. Future Oncol 2009; 5: 1051-63.
16. Abrams J A. Obesity and Barrett's oesophagus: more than just reflux. Gut 2009; 58: 1437-8.
17. Wolin K Y, Carson K, Colditz G A. Obesity and cancer. Oncologist 2010; 15: 556-65.
18. Beddy P, Howard J, McMahon C etal. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg 2010; 97: 1028-34.
19. Howard J M, Beddy P, Ennis D, Keogan M, Pidgeon G P, Reynolds J V. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg 2010; 97: 1020-7.
20. Sinicrope F A, Dannenberg A J. Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 2011; 29: 4-7.
21. Renehan A G, Roberts D L, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 2008; 114: 71-83.
22. Rasouli N, Kern P A. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93 (Suppl 1): S64-73.
23. El-Serag H B, Kvapil P, Hacken-Bitar J, Kramer J R. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005; 100: 2151-6.
24. Phipps A I, Chlebowski R T, Prentice R etal. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 454-63. Epub 2011 Mar 1.
25. Braiteh F, Correa A M, Hofstetter W L etal. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 2009; 115: 4450-8.